Effects of Armodafinil and Cognitive Behavior Therapy for Insomnia on Sleep Continuity and Daytime Sleepiness in Cancer Survivors

STUDY OBJECTIVES: This study involves the analysis of a secondary outcome of a trial examining whether cognitive behavior therapy for insomnia (CBT-I), a wake-promoting medication (armodafinil), or both results in greater improvement in prospectively assessed sleep continuity and daytime sleepiness...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sleep Med
Autors principals: Garland, Sheila N., Roscoe, Joseph A., Heckler, Charles E., Barilla, Holly, Gehrman, Philip, Findley, James C., Peoples, Anita R., Morrow, Gary R., Kamen, Charles, Perlis, Michael L.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5267578/
https://ncbi.nlm.nih.gov/pubmed/27318221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sleep.2015.12.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars